July / August 2012
Addressing pharmaceutical industry disruptors with virtual partnerships, corporate renewal and active risk management
Strong R&D will continue to spur the development of great new pharma therapies and molecules. But to make those…Patenting and innovation strategies in China
For years, a red-shaded map of China’s intellectual property regime would show the strongest IP protection in the…The leadership immunity to making things happen
What gets measured may get managed, but what if a leader doesn’t know what needs to get measured? In fact, what if…One-liners for Executives
One-liners are very short statements that purport to capture the essence of a situation. At their best, they can bring……Frugal innovation: the key to penetrating emerging markets
There may be no better exemplar of the need to modify business practices when expanding to another country than innovation.……On becoming an IT savvy CEO
A leader today doesn’t need to know how to store information on a “cloud,” for example, but he or she does need…
Why Big Data is the new competitive advantage
Many observers, including the authors of this article, believe that Big Data is the new, new thing that will see some…
